Cargando…
Safety of activated recombinant factor VII in patients with circulatory assist devices
Autores principales: | Schneider, AS, Tozzi, P, Voirol, P, Schoettker, P, Perez, MH, Angelillo-Scherrer, A, Wasserfallen, J, Chiolero, R, Cotting, J, Von Segesser, L, Eggimann, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084317/ http://dx.doi.org/10.1186/cc7595 |
Ejemplares similares
-
Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009) -
Five-year evolution of drug prescribing in a university adult intensive care unit
por: Voirol, P, et al.
Publicado: (2010) -
Recombinant Activated Factor VII in Aortic Surgery for Patients Under Hypothermic Circulatory Arrest
por: Ise, Hayato, et al.
Publicado: (2022) -
Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant
por: Gandhi, Manish J, et al.
Publicado: (2007) -
Heart Failure and Mechanical Circulatory Assist Devices
por: Franca, Eluisa La, et al.
Publicado: (2013)